We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$107B
AUM Growth
-$4.88B
Cap. Flow
+$802M
Cap. Flow %
0.75%
Top 10 Hldgs %
28.03%
Holding
4,262
New
46
Increased
1,724
Reduced
2,093
Closed
87

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$78.7M
2
XYZ
Block Inc
XYZ
+$49.3M
3
V icon
Visa
V
+$46.1M
4
AAPL icon
Apple
AAPL
+$45.4M
5
DASH icon
DoorDash
DASH
+$45.1M

Sector Composition

Rank Sector Weight
1 Technology 28.67%
2 Financials 14.43%
3 Healthcare 10.97%
4 Consumer Discretionary 10.82%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KNBWY
3201
DELISTED
KIRIN BREWERY LTD SPONSORED ADR
KNBWY
$56.7K ﹤0.01%
4,073
CANF
3202
Can-Fite BioPharma American Depositary Shares
CANF
$7.37M
$56.6K ﹤0.01%
1,913
+569
+42% +$18.1K
TPIC
3203
DELISTED
TPI Composites
TPIC
$56.5K ﹤0.01%
70,074
-3,022
-4% -$3.95K
HEPS
3204
D-Market Electronic Services & Trading
HEPS
$990M
$55K ﹤0.01%
19,296
+4,081
+27% +$13.2K
XNET
3205
Xunlei
XNET
$326M
$54.9K ﹤0.01%
12,222
-11,875
-49% -$39.6K
ULBI icon
3206
Ultralife
ULBI
$106M
$54.6K ﹤0.01%
10,154
-42
-0.4% -$285
REKR icon
3207
Rekor Systems
REKR
$91.7M
$54.6K ﹤0.01%
61,572
+137
+0.2% +$216
LK
3208
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
$54.2K ﹤0.01%
1,567
-143
-8% -$4.95K
BESI
3209
DELISTED
BE SEMICONDCTR INDS NV NY REGS
BESI
$54K ﹤0.01%
520
+310
+148% +$32.2K
FINV
3210
FinVolution Group
FINV
$1.15B
$53.6K ﹤0.01%
5,562
-11,594
-68% -$95.1K
CRVO icon
3211
CervoMed
CRVO
$26.6M
$53.3K ﹤0.01%
5,830
+1,526
+35% +$5.81K
MRSN
3212
DELISTED
Mersana Therapeutics
MRSN
$53K ﹤0.01%
6,167
-707
-10% -$10.9K
CTNM
3213
Contineum Therapeutics
CTNM
$566M
$52.9K ﹤0.01%
7,573
-660
-8% -$6K
MOMO
3214
Hello Group
MOMO
$866M
$52.7K ﹤0.01%
8,352
-3,930
-32% -$28.4K
GOCO
3215
DELISTED
GoHealth
GOCO
$52.6K ﹤0.01%
4,287
+119
+3% +$1.82K
ENOR icon
3216
iShares MSCI Norway ETF
ENOR
$96M
$52.2K ﹤0.01%
2,010
+380
+23% +$9.19K
NOMD icon
3217
Nomad Foods
NOMD
$1.68B
$52.1K ﹤0.01%
2,653
METCB icon
3218
Ramaco Resources Class B
METCB
$408M
$52.1K ﹤0.01%
7,720
+159
+2% +$1.34K
ZTO icon
3219
ZTO Express
ZTO
$17.9B
$51.7K ﹤0.01%
2,604
-12,584
-83% -$246K
CVGI icon
3220
Commercial Vehicle Group
CVGI
$147M
$51.5K ﹤0.01%
44,818
-4,793
-10% -$9.27K
ZYXI
3221
DELISTED
Zynex
ZYXI
$51.4K ﹤0.01%
23,382
+1,371
+6% +$8.95K
TIGR
3222
UP Fintech Holding
TIGR
$860M
$50.8K ﹤0.01%
5,912
-890
-13% -$6.65K
RAPT
3223
DELISTED
RAPT Therapeutics
RAPT
$50.8K ﹤0.01%
5,203
-571
-10% -$5.62K
EDEN icon
3224
iShares MSCI Denmark ETF
EDEN
$206M
$50.7K ﹤0.01%
488
+140
+40% +$15.1K
BILI icon
3225
Bilibili
BILI
$7.84B
$50.4K ﹤0.01%
2,639
-1,320
-33% -$25.4K

Similar funds

RhumbLine Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, RhumbLine Advisers held 4,262 positions worth $107B, down 4.4% from $112B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 3.1%. RhumbLine Advisers opened 46 new positions and exited 87, leaving the 4,262-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2025 buy was Block Inc: 660,293 shares worth $35.9M.
  • RhumbLine Advisers added most to iShares Russell 2000 ETF in Q1 2025, an estimated $78.7M increase.
  • RhumbLine Advisers's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $78.8M.
  • RhumbLine Advisers fully exited Aspen Technology Inc in Q1 2025, selling an estimated $19.7M.
  • RhumbLine Advisers's ten largest holdings make up 28% of its $107B portfolio in Q1 2025.
  • RhumbLine Advisers opened 46 new positions and closed 87 in Q1 2025.
  • RhumbLine Advisers's portfolio value fell 4.4% quarter-over-quarter to $107B.

Based on RhumbLine Advisers's 13F filing for Q1 2025, filed 8 Apr 2025.